Gabriele Matschiner

Company: Pieris Pharmaceuticals

Job title: Director Respiratory

Seminars:

Anticalin Platform for Development of Inhaled Therapies in Chronic Airway Disease 2:00 pm

Bullet points: inhaled Anticalin antagonists for respiratory disease Benefits of local intervention via inhalation versus systemic administration Development of PRS-060, a potential first-in-class, inhaled IL-4Ra inhibitor for the treatment of asthmaRead more

day: Conference Day 1